Arecor Therapeutics plc (LON:AREC – Get Free Report)’s stock price reached a new 52-week low during trading on Tuesday . The stock traded as low as GBX 42 ($0.54) and last traded at GBX 42 ($0.54), with a volume of 70955 shares. The stock had previously closed at GBX 43.50 ($0.56).
Arecor Therapeutics Trading Down 3.4 %
The stock’s fifty day simple moving average is GBX 52.22 and its two-hundred day simple moving average is GBX 64.57. The firm has a market cap of £15.86 million, a PE ratio of -1.48 and a beta of -0.18. The company has a quick ratio of 6.24, a current ratio of 1.37 and a debt-to-equity ratio of 5.51.
About Arecor Therapeutics
Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products.
Featured Stories
- Five stocks we like better than Arecor Therapeutics
- Basic Materials Stocks Investing
- D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- Are Penny Stocks a Good Fit for Your Portfolio?
- Buffett Trims Equities, But Still Keeps Buying This Stock
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
